This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Elanix Biotechnologies Balans Gezondheid
Financiële gezondheid criteriumcontroles 0/6
Insufficient data to determine the health of Elanix Biotechnologies
Belangrijke informatie
n/a
Verhouding schuld/eigen vermogen
n/a
Schuld
| Rente dekkingsratio | n/a |
| Contant | n/a |
| Aandelen | n/a |
| Totaal verplichtingen | n/a |
| Totaal activa | n/a |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: Insufficient data to determine if ELN's short term assets cover its short term liabilities.
Langlopende schulden: Insufficient data to determine if ELN's short term assets cover its long term liabilities.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: Insufficient data to calculate ELN's net debt to equity ratio to determine if it is satisfactory.
Schuld verminderen: Insufficient data to determine if ELN's debt to equity ratio has reduced over the past 5 years.
Schuldendekking: Insufficient data to determine if ELN's debt is well covered by operating cash flow.
Rentedekking: Insufficient data to determine if ELN's interest payments on its debt are well covered by EBIT.